ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.065,44
-1,55%
S&P 500
5.702,55
-0,19%
US Dollar vs BRL
5,5151
0,01%
Bitcoin
63.274,68
0,11%
Brent Oil
74,135
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Notícias

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNXP
DataHoraFonteTítuloCódigoCompanhia
20/09/202418:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/09/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/09/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat MigrainesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/09/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO’s Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health EmergencyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/09/202418:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
10/09/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial OperationsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
09/09/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of AlbertaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/09/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeekNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/08/202418:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
29/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
28/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
26/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix’s Mpox Vaccine, TNX-801NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
21/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
20/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine IntoxicationNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
19/08/202407:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/08/202418:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
16/08/202408:00GlobeNewswire Inc.Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health EmergencyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
15/08/202407:03Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
13/08/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor SummitNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/08/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on PainNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
06/08/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company’s Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other PathogensNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
31/07/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya™NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
30/07/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on PainNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
25/07/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
24/07/202418:14Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
10/07/202417:30GlobeNewswire Inc.Tonix Pharmaceuticals Announces Closing of $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
09/07/202410:15GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/07/202418:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Proposed Public OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
08/07/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/07/202409:00GlobeNewswire Inc.Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral ProgramNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:TNXP

Seu Histórico Recente

LSE
01QA
Res.mort.erc's'
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados